Real-world evidence strategy and analyses

Across the whole clinical development journey and beyond, the role of real-world evidence (RWE) is increasing in importance as regulators and payers are now accepting RWE as a complementary source of evidence to clinical trials.


Our solutions harness the power of our extensive clinician and payer expert network to delve deeper into multiple elements that drive your market access strategy. We use our database analysis capabilities to take advantage of advances in data curation and analytics that make existing real-world data more accessible.


Our consulting solutions include:

  • bespoke clinician/payer surveys
  • Delphi panels
  • comparative effectiveness studies
  • RWE analytics (healthcare claims, hospital admissions data, and electronic medical records analyses)
  • burden of illness studies
  • costing studies.


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

You helped us achieve higherquality outputs through this wonderful process. Thank you for managing the panel preparation and facilitation.

Global Market Access Lead, top-5 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.